NEFL and Parkinson disease: Despite having heterogeneous pathology within the combined APS group, it is possible that the markers reaching significance in the above analyses are, like NF-L, non-specific markers of more rapid rates of neurodegeneration seen in PSP, CBS and MSA in comparison with PD.